Lianyu Zhao

机构：Shandong Provincial Hospital, Shandong First Medical University · ORCID：0000-0002-3072-9084

发表论文 14 篇 · 总被引 258 次 · h-index 6

代表论文

• Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances (2024 · Signal Transduction and Targeted Therapy · 被引 181)
• Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis (2022 · Frontiers in Immunology · 被引 30)
• Effectiveness of Yishen Tongbi decoction versus methotrexate in patients with active rheumatoid arthritis: A double-blind, randomized, controlled, non-inferiority trial (2023 · Phytomedicine · 被引 15)
• Yishen-tongbi decoction inhibits excessive activation of B cells by activating the FcγRIIb/Lyn/SHP-1 pathway and attenuates the inflammatory response in CIA rats (2020 · Biomedicine & Pharmacotherapy · 被引 10)
• Chloroquine and Rapamycin Augment Interleukin‐37 Expression via the LC3, ERK, and AP‐1 Axis in the Presence of Lipopolysaccharides (2020 · Journal of Immunology Research · 被引 10)
• Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis (2023 · International Immunopharmacology · 被引 6)